Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Neto BV"'
Autor:
Neto BV; Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP)/Pathology and Laboratory Medicine Dep, Clinical Pathology SV/ RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto) / Porto Comprehensive Cancer Centre (Porto.CCC), Porto, 4200-072, Portugal.; Research Department, Portuguese League Against Cancer (NRNorte), Porto, 4200-172, Portugal., Tavares V; Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP)/Pathology and Laboratory Medicine Dep, Clinical Pathology SV/ RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto) / Porto Comprehensive Cancer Centre (Porto.CCC), Porto, 4200-072, Portugal.; Faculty of Medicine, University of Porto (FMUP), Porto, 4200-072, Portugal.; Instituto de Ciências Biomédicas Abel Salazar, ICBAS, Universidade do Porto, Porto, Portugal., da Silva JB; Oncology Department, Portuguese Institute of Oncology of Porto (IPOP), Porto, 4200-072, Portugal., Liz-Pimenta J; Faculty of Medicine, University of Porto (FMUP), Porto, 4200-072, Portugal.; Department of Medical Oncology, Centro Hospitalar de Trás-os-Montes e Alto Douro (CHTMAD), Vila Real, 5000-508, Portugal., Marques IS; Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP)/Pathology and Laboratory Medicine Dep, Clinical Pathology SV/ RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto) / Porto Comprehensive Cancer Centre (Porto.CCC), Porto, 4200-072, Portugal., Salgado L; External Radiotherapy Department, Portuguese Institute of Oncology of Porto (IPOP), Porto, 4200-072, Portugal., Carvalho L; External Radiotherapy Department, Portuguese Institute of Oncology of Porto (IPOP), Porto, 4200-072, Portugal., Pereira D; Oncology Department, Portuguese Institute of Oncology of Porto (IPOP), Porto, 4200-072, Portugal., Medeiros R; Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP)/Pathology and Laboratory Medicine Dep, Clinical Pathology SV/ RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto) / Porto Comprehensive Cancer Centre (Porto.CCC), Porto, 4200-072, Portugal. ruimedei@ipoporto.min-saude.pt.; Research Department, Portuguese League Against Cancer (NRNorte), Porto, 4200-172, Portugal. ruimedei@ipoporto.min-saude.pt.; Faculty of Medicine, University of Porto (FMUP), Porto, 4200-072, Portugal. ruimedei@ipoporto.min-saude.pt.; Instituto de Ciências Biomédicas Abel Salazar, ICBAS, Universidade do Porto, Porto, Portugal. ruimedei@ipoporto.min-saude.pt.; External Radiotherapy Department, Portuguese Institute of Oncology of Porto (IPOP), Porto, 4200-072, Portugal. ruimedei@ipoporto.min-saude.pt.
Publikováno v:
Journal of thrombosis and thrombolysis [J Thromb Thrombolysis] 2024 Jun; Vol. 57 (5), pp. 815-827. Date of Electronic Publication: 2024 Apr 20.
Autor:
Tavares V; Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP)/ Pathology and Laboratory Medicine Dep., Clinical Pathology SV/ RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto) / Porto Comprehensive Cancer Centre (Porto.CCC), 4200-072 Porto, Portugal; Faculty of Medicine of University of Porto (FMUP), 4200-072 Porto, Portugal; Abel Salazar Institute for the Biomedical Sciences (ICBAS), University of Porto, 4050-313 Porto, Portugal., Neto BV; Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP)/ Pathology and Laboratory Medicine Dep., Clinical Pathology SV/ RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto) / Porto Comprehensive Cancer Centre (Porto.CCC), 4200-072 Porto, Portugal; Research Department, Portuguese League Against Cancer (NRNorte), 4200-172 Porto, Portugal., Marques IS; Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP)/ Pathology and Laboratory Medicine Dep., Clinical Pathology SV/ RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto) / Porto Comprehensive Cancer Centre (Porto.CCC), 4200-072 Porto, Portugal; Faculty of Sciences of University of Porto (FCUP), 4169-007 Porto, Portugal., Assis J; Clinical Research Unit, Research Center of IPO Porto (CI-IPOP) / RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto) / Porto Comprehensive Cancer Center (Porto.CCC), 4200-072 Porto, Portugal., Pereira D; Oncology Department, Portuguese Institute of Oncology of Porto (IPO Porto), 4200-072 Porto, Portugal., Medeiros R; Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP)/ Pathology and Laboratory Medicine Dep., Clinical Pathology SV/ RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto) / Porto Comprehensive Cancer Centre (Porto.CCC), 4200-072 Porto, Portugal; Faculty of Medicine of University of Porto (FMUP), 4200-072 Porto, Portugal; Abel Salazar Institute for the Biomedical Sciences (ICBAS), University of Porto, 4050-313 Porto, Portugal; Research Department, Portuguese League Against Cancer (NRNorte), 4200-172 Porto, Portugal; Faculty of Health Sciences, Fernando Pessoa University, 4200-150 Porto, Portugal. Electronic address: ruimedei@ipoporto.min-saude.pt.
Publikováno v:
Biochimica et biophysica acta. Reviews on cancer [Biochim Biophys Acta Rev Cancer] 2024 Jan; Vol. 1879 (1), pp. 189053. Date of Electronic Publication: 2023 Dec 12.
Autor:
Silva HH; ICBAS-Institute of Biomedical Sciences, University of Porto, 4050-313 Porto, Portugal.; Portuguese Ministry of Education, 1399-025 Lisbon, Portugal.; Leixões Sport Clube, Senior Female Volleyball Team, 4450-277 Matosinhos, Portugal., Tavares V; ICBAS-Institute of Biomedical Sciences, University of Porto, 4050-313 Porto, Portugal.; Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP)/RISE@CI-IPOP, Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center (Porto.CCC), 4200-072 Porto, Portugal.; FMUP-Faculty of Medicine, University of Porto, 4200-072 Porto, Portugal., Neto BV; Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP)/RISE@CI-IPOP, Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center (Porto.CCC), 4200-072 Porto, Portugal.; LPCC, Research Department-Portuguese League Against Cancer (LPPC-NRN), 4200-172 Porto, Portugal., Cerqueira F; Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP)/RISE@CI-IPOP, Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center (Porto.CCC), 4200-072 Porto, Portugal.; FP-I3ID, FP-BHS, CEBIMED and Faculty of Health Sciences, University Fernando Pessoa, 4200-150 Porto, Portugal.; CIIMAR/CIMAR, Interdisciplinary Centre of Marine and Environmental Research, 4450-208 Matosinhos, Portugal., Medeiros R; Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP)/RISE@CI-IPOP, Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center (Porto.CCC), 4200-072 Porto, Portugal.; FMUP-Faculty of Medicine, University of Porto, 4200-072 Porto, Portugal.; LPCC, Research Department-Portuguese League Against Cancer (LPPC-NRN), 4200-172 Porto, Portugal.; FP-I3ID, FP-BHS, CEBIMED and Faculty of Health Sciences, University Fernando Pessoa, 4200-150 Porto, Portugal.; Pathology and Laboratory Medicine Department, Clinical Pathology SVIPO Porto Portuguese Oncology Institute of Porto, 4200-072 Porto, Portugal., Silva MG; FP-I3ID, FP-BHS, CEBIMED and Faculty of Health Sciences, University Fernando Pessoa, 4200-150 Porto, Portugal.; CIAS-Research Centre for Anthropology and Health-Human Biology, Health and Society, University of Coimbra, 3000-456 Coimbra, Portugal.; CHRC-Comprehensive Health Research Centre, Nova Medical School, Nova University of Lisbon, 1150-090 Lisboa, Portugal.; Scientific Committee of the Gymnastics Federation of Portugal, 1600-159 Lisboa, Portugal.
Publikováno v:
Genes [Genes (Basel)] 2023 Oct 16; Vol. 14 (10). Date of Electronic Publication: 2023 Oct 16.
Autor:
Marques IS; Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP)/Pathology and Laboratory Medicine Dep., Clinical Pathology SV/RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Centre (Porto.CCC), 4200-072 Porto, Portugal.; Faculty of Sciences of University of Porto (FCUP), 4169-007 Porto, Portugal., Tavares V; Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP)/Pathology and Laboratory Medicine Dep., Clinical Pathology SV/RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Centre (Porto.CCC), 4200-072 Porto, Portugal.; Faculty of Medicine of University of Porto (FMUP), 4200-072 Porto, Portugal.; Abel Salazar Institute for the Biomedical Sciences (ICBAS), University of Porto, 4050-313 Porto, Portugal., Neto BV; Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP)/Pathology and Laboratory Medicine Dep., Clinical Pathology SV/RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Centre (Porto.CCC), 4200-072 Porto, Portugal.; Research Department, Portuguese League Against Cancer (NRNorte), 4200-172 Porto, Portugal., Mota INR; Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP)/Pathology and Laboratory Medicine Dep., Clinical Pathology SV/RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Centre (Porto.CCC), 4200-072 Porto, Portugal.; Faculty of Sciences of University of Porto (FCUP), 4169-007 Porto, Portugal., Pereira D; Oncology Department, Portuguese Institute of Oncology of Porto (IPOP), 4200-072 Porto, Portugal., Medeiros R; Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP)/Pathology and Laboratory Medicine Dep., Clinical Pathology SV/RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Centre (Porto.CCC), 4200-072 Porto, Portugal.; Faculty of Medicine of University of Porto (FMUP), 4200-072 Porto, Portugal.; Abel Salazar Institute for the Biomedical Sciences (ICBAS), University of Porto, 4050-313 Porto, Portugal.; Research Department, Portuguese League Against Cancer (NRNorte), 4200-172 Porto, Portugal.; Faculty of Health Sciences, Fernando Pessoa University, 4200-150 Porto, Portugal.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2023 Jul 28; Vol. 24 (15). Date of Electronic Publication: 2023 Jul 28.
Autor:
Neto BV; Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP)/ Pathology and Laboratory Medicine Dep., Clinical Pathology SV/ RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto) / Porto Comprehensive Cancer Centre (Porto.CCC), 4200-072, Porto, Portugal.; FMUP, Faculty of Medicine, University of Porto, 4200-072, Porto, Portugal.; Research Department, Portuguese League Against Cancer (NRNorte), 4200-172, Porto, Portugal., Tavares V; Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP)/ Pathology and Laboratory Medicine Dep., Clinical Pathology SV/ RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto) / Porto Comprehensive Cancer Centre (Porto.CCC), 4200-072, Porto, Portugal.; FMUP, Faculty of Medicine, University of Porto, 4200-072, Porto, Portugal.; ICBAS, Abel Salazar Institute for the Biomedical Sciences, Rua de Jorge Viterbo Ferreira, 228, 4050-313, Porto, Portugal.; Research Department, Portuguese League Against Cancer (NRNorte), 4200-172, Porto, Portugal., da Silva JB; Oncology Department, Portuguese Institute of Oncology of Porto (IPOP), 4200-072, Porto, Portugal., Liz-Pimenta J; FMUP, Faculty of Medicine, University of Porto, 4200-072, Porto, Portugal.; Department of Medical Oncology, Centro Hospitalar de Trás-os-Montes e Alto Douro (CHTMAD), 5000-508, Vila Real, Portugal., Marques IS; Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP)/ Pathology and Laboratory Medicine Dep., Clinical Pathology SV/ RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto) / Porto Comprehensive Cancer Centre (Porto.CCC), 4200-072, Porto, Portugal.; FCUP, Faculty of Sciences, University of Porto, 4169-007, Porto, Portugal., Carvalho L; External Radiotherapy Department, Portuguese Institute of Oncology of Porto (IPOP), 4200-072, Porto, Portugal., Salgado L; External Radiotherapy Department, Portuguese Institute of Oncology of Porto (IPOP), 4200-072, Porto, Portugal., Pereira D; Oncology Department, Portuguese Institute of Oncology of Porto (IPOP), 4200-072, Porto, Portugal., Medeiros R; Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP)/ Pathology and Laboratory Medicine Dep., Clinical Pathology SV/ RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto) / Porto Comprehensive Cancer Centre (Porto.CCC), 4200-072, Porto, Portugal. ruimedei@ipoporto.min-saude.pt.; FMUP, Faculty of Medicine, University of Porto, 4200-072, Porto, Portugal. ruimedei@ipoporto.min-saude.pt.; ICBAS, Abel Salazar Institute for the Biomedical Sciences, Rua de Jorge Viterbo Ferreira, 228, 4050-313, Porto, Portugal. ruimedei@ipoporto.min-saude.pt.; FCUP, Faculty of Sciences, University of Porto, 4169-007, Porto, Portugal. ruimedei@ipoporto.min-saude.pt.; Research Department, Portuguese League Against Cancer (NRNorte), 4200-172, Porto, Portugal. ruimedei@ipoporto.min-saude.pt.; CEBIMED, Faculty of Health Sciences, Fernando Pessoa University, 4200-150, Porto, Portugal. ruimedei@ipoporto.min-saude.pt.
Publikováno v:
Scientific reports [Sci Rep] 2023 Jun 12; Vol. 13 (1), pp. 9519. Date of Electronic Publication: 2023 Jun 12.
Autor:
Liz-Pimenta J; Department of Medical Oncology, Centro Hospitalar de Trás-os-Montes e Alto Douro, 5000-508 Vila Real, Portugal; FMUP, Faculty of Medicine, University of Porto, 4200-072 Porto, Portugal., Tavares V; FMUP, Faculty of Medicine, University of Porto, 4200-072 Porto, Portugal; ICBAS, Abel Salazar Institute for the Biomedical Sciences, 4050-313 Porto, Portugal; Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP) / Pathology and Laboratory Medicine Dep., Clinical Pathology SV/ RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto) / Porto Comprehensive Cancer Center (Porto.CCC), 4200-072 Porto, Portugal., Neto BV; FMUP, Faculty of Medicine, University of Porto, 4200-072 Porto, Portugal; Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP) / Pathology and Laboratory Medicine Dep., Clinical Pathology SV/ RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto) / Porto Comprehensive Cancer Center (Porto.CCC), 4200-072 Porto, Portugal., Santos JMO; FMUP, Faculty of Medicine, University of Porto, 4200-072 Porto, Portugal; Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP) / Pathology and Laboratory Medicine Dep., Clinical Pathology SV/ RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto) / Porto Comprehensive Cancer Center (Porto.CCC), 4200-072 Porto, Portugal., Guedes CB; Department of Imunohemotherapy, Hospital da Senhora da Oliveira, 4835-044 Guimarães, Portugal., Araújo A; Department of Medical Oncology, Centro Hospitalar Universitário do Porto, 4099-001 Porto, Portugal; UMIB - Unidade Multidisciplinar de Investigação Biomédica, ICBAS - Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Porto, Portugal., Khorana AA; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH 44106, United States., Medeiros R; FMUP, Faculty of Medicine, University of Porto, 4200-072 Porto, Portugal; ICBAS, Abel Salazar Institute for the Biomedical Sciences, 4050-313 Porto, Portugal; Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP) / Pathology and Laboratory Medicine Dep., Clinical Pathology SV/ RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto) / Porto Comprehensive Cancer Center (Porto.CCC), 4200-072 Porto, Portugal; Research Department, Portuguese League Against Cancer - Regional Nucleus of the North, 4200-172 Porto, Portugal; Biomedical Research Center, Faculty of Health Sciences of the Fernando Pessoa University, 4249-004 Porto, Portugal. Electronic address: ruimedei@ipoporto.min-saude.pt.
Publikováno v:
Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2023 Jun; Vol. 186, pp. 103989. Date of Electronic Publication: 2023 Apr 13.
Association of FAAH rs324420 (C385A) Polymorphism with High-Level Performance in Volleyball Players.
Autor:
Silva HH; ICBAS-Institute of Biomedical Sciences, University of Porto, 4050-313 Porto, Portugal.; Portuguese Ministry of Education, 1399-025 Lisboa, Portugal.; Senior Rink-Hockey Team, Uniao Desportiva Oliveirense-Simoldes, 3720-256 Oliveira de Azemeis, Portugal., Tavares V; ICBAS-Institute of Biomedical Sciences, University of Porto, 4050-313 Porto, Portugal.; Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP)/RISE@CI-IPOP, Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center (Porto.CCC), 4200-072 Porto, Portugal.; FMUP-Faculty of Medicine, University of Porto, 4200-072 Porto, Portugal., Silva MG; FP-I3ID, FP-BHS, University Fernando Pessoa, 4249-004 Porto, Portugal.; Faculty of Health Sciences, University Fernando Pessoa, 4200-150 Porto, Portugal.; CIAS-Research Centre for Anthropology and Health-Human Biology, Health and Society, University of Coimbra, 3000-456 Coimbra, Portugal.; CHRC-Comprehensive Health Research Centre, Nova Medical School, Nova University of Lisbon, 1150-090 Lisboa, Portugal.; Scientific Committee of the Gymnastics Federation of Portugal, 1600-159 Lisboa, Portugal., Neto BV; Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP)/RISE@CI-IPOP, Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center (Porto.CCC), 4200-072 Porto, Portugal.; FMUP-Faculty of Medicine, University of Porto, 4200-072 Porto, Portugal., Cerqueira F; Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP)/RISE@CI-IPOP, Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center (Porto.CCC), 4200-072 Porto, Portugal.; FP-I3ID, FP-BHS, University Fernando Pessoa, 4249-004 Porto, Portugal.; Faculty of Health Sciences, University Fernando Pessoa, 4200-150 Porto, Portugal.; CIIMAR/CIMAR, Interdisciplinary Centre of Marine and Environmental Research, 4450-208 Matosinhos, Portugal., Medeiros R; Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP)/RISE@CI-IPOP, Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center (Porto.CCC), 4200-072 Porto, Portugal.; FMUP-Faculty of Medicine, University of Porto, 4200-072 Porto, Portugal.; FP-I3ID, FP-BHS, University Fernando Pessoa, 4249-004 Porto, Portugal.; Faculty of Health Sciences, University Fernando Pessoa, 4200-150 Porto, Portugal.; Pathology and Laboratory Medicine Department, Clinical Pathology SVIPO Porto Portuguese Oncology Institute of Porto, 4200-072 Porto, Portugal.; LPCC, Research Department, Portuguese League Against Cancer (LPPC-NRN), 4200-172 Porto, Portugal.
Publikováno v:
Genes [Genes (Basel)] 2023 May 26; Vol. 14 (6). Date of Electronic Publication: 2023 May 26.
Autor:
Neto BV; Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP)/ Pathology and Laboratory Medicine Dep., Clinical Pathology SV/ RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center (Porto.CCC), 4200-072, Porto, Portugal.; FMUP, Faculty of Medicine, University of Porto, 4200-072, Porto, Portugal., Tavares V; Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP)/ Pathology and Laboratory Medicine Dep., Clinical Pathology SV/ RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center (Porto.CCC), 4200-072, Porto, Portugal.; FMUP, Faculty of Medicine, University of Porto, 4200-072, Porto, Portugal.; ICBAS, Abel Salazar Institute for the Biomedical Sciences, Rua de Jorge Viterbo Ferreira, 228, 4050-313, Porto, Portugal., Santos JMO; Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP)/ Pathology and Laboratory Medicine Dep., Clinical Pathology SV/ RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center (Porto.CCC), 4200-072, Porto, Portugal.; FMUP, Faculty of Medicine, University of Porto, 4200-072, Porto, Portugal., Cerqueira F; Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP)/ Pathology and Laboratory Medicine Dep., Clinical Pathology SV/ RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center (Porto.CCC), 4200-072, Porto, Portugal.; FP-I3ID, FP-ENAS, FP-BHS, University Fernando Pessoa, Praça 9 de Abril, 349, 4249-004, Porto, Portugal.; Faculty of Health Sciences, University Fernando Pessoa, Rua Carlos da Maia, 296, 4200-150, Porto, Portugal., Pereira D; Oncology Department, Portuguese Institute of Oncology of Porto (IPOP), 4200-072, Porto, Portugal., Medeiros R; Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP)/ Pathology and Laboratory Medicine Dep., Clinical Pathology SV/ RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center (Porto.CCC), 4200-072, Porto, Portugal. ruimedei@ipoporto.min-saude.pt.; FMUP, Faculty of Medicine, University of Porto, 4200-072, Porto, Portugal. ruimedei@ipoporto.min-saude.pt.; ICBAS, Abel Salazar Institute for the Biomedical Sciences, Rua de Jorge Viterbo Ferreira, 228, 4050-313, Porto, Portugal. ruimedei@ipoporto.min-saude.pt.; FP-I3ID, FP-ENAS, FP-BHS, University Fernando Pessoa, Praça 9 de Abril, 349, 4249-004, Porto, Portugal. ruimedei@ipoporto.min-saude.pt.; Faculty of Health Sciences, University Fernando Pessoa, Rua Carlos da Maia, 296, 4200-150, Porto, Portugal. ruimedei@ipoporto.min-saude.pt.; Research Department, Portuguese League Against Cancer (NRNorte), 4200-172, Porto, Portugal. ruimedei@ipoporto.min-saude.pt.
Publikováno v:
Discover oncology [Discov Oncol] 2023 Jan 08; Vol. 14 (1), pp. 3. Date of Electronic Publication: 2023 Jan 08.
Autor:
Tavares V; Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP) / Pathology and Laboratory Medicine Dep., Clinical Pathology SV/ RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto) / Porto Comprehensive Cancer Center (Porto.CCC), 4200-072 Porto, Portugal; ICBAS, Abel Salazar Institute for the Biomedical Sciences, 4050-313 Porto, Portugal; FMUP, Faculty of Medicine, University of Porto, 4200-072 Porto, Portugal., Neto BV; Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP) / Pathology and Laboratory Medicine Dep., Clinical Pathology SV/ RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto) / Porto Comprehensive Cancer Center (Porto.CCC), 4200-072 Porto, Portugal; FMUP, Faculty of Medicine, University of Porto, 4200-072 Porto, Portugal., Vilas-Boas MI; Oncology Department, Portuguese Institute of Oncology of Porto (IPOP), 4200-072 Porto, Portugal., Pereira D; Oncology Department, Portuguese Institute of Oncology of Porto (IPOP), 4200-072 Porto, Portugal., Medeiros R; Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP) / Pathology and Laboratory Medicine Dep., Clinical Pathology SV/ RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto) / Porto Comprehensive Cancer Center (Porto.CCC), 4200-072 Porto, Portugal; ICBAS, Abel Salazar Institute for the Biomedical Sciences, 4050-313 Porto, Portugal; FMUP, Faculty of Medicine, University of Porto, 4200-072 Porto, Portugal; CEBIMED, Faculty of Health Sciences, Fernando Pessoa University, 4200-150 Porto, Portugal; Research Department, Portuguese League Against Cancer (NRNorte), 4200-172 Porto, Portugal. Electronic address: ruimedei@ipoporto.min-saude.pt.
Publikováno v:
Biochimica et biophysica acta. Reviews on cancer [Biochim Biophys Acta Rev Cancer] 2022 Sep; Vol. 1877 (5), pp. 188778. Date of Electronic Publication: 2022 Aug 10.
Autor:
Silva HH; ICBAS-Institute of Biomedical Sciences, University of Porto, 4050-313 Porto, Portugal.; Portuguese Ministry of Education, 1399-025 Lisbon, Portugal.; Senior Rink-Hockey Team, União Desportiva Oliveirense-Simoldes, 3720-256 Oliveira de Azemeis, Portugal., Tavares V; ICBAS-Institute of Biomedical Sciences, University of Porto, 4050-313 Porto, Portugal.; Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP)/RISE@CI-IPOP, Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center (Porto.CCC), 4200-072 Porto, Portugal.; FMUP-Faculty of Medicine, University of Porto, 4200-072 Porto, Portugal., Silva MG; FP-I3ID, FP-BHS, CEBIMED and Faculty of Health Sciences, University Fernando Pessoa, 4200-150 Porto, Portugal.; CIAS-Research Centre for Anthropology and Health-Human Biology, Health and Society, University of Coimbra, 3000-456 Coimbra, Portugal.; CHRC-Comprehensive Health Research Centre, Nova Medical School, Nova University of Lisbon, 1150-090 Lisbon, Portugal.; Scientific Committee of the Gymnastics Federation of Portugal, 1600-159 Lisbon, Portugal., Neto BV; Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP)/RISE@CI-IPOP, Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center (Porto.CCC), 4200-072 Porto, Portugal.; FMUP-Faculty of Medicine, University of Porto, 4200-072 Porto, Portugal., Cerqueira F; Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP)/RISE@CI-IPOP, Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center (Porto.CCC), 4200-072 Porto, Portugal.; FP-I3ID, FP-BHS, CEBIMED and Faculty of Health Sciences, University Fernando Pessoa, 4200-150 Porto, Portugal.; CIIMAR/CIMAR, Interdisciplinary Centre of Marine and Environmental Research, 4450-208 Matosinhos, Portugal., Medeiros R; Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP)/RISE@CI-IPOP, Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center (Porto.CCC), 4200-072 Porto, Portugal.; FMUP-Faculty of Medicine, University of Porto, 4200-072 Porto, Portugal.; FP-I3ID, FP-BHS, CEBIMED and Faculty of Health Sciences, University Fernando Pessoa, 4200-150 Porto, Portugal.; Pathology and Laboratory Medicine Dep., Clinical Pathology SVIPO Porto Portuguese Oncology Institute of Porto, 4200-072 Porto, Portugal.; LPCC, Research Department, Portuguese League Against Cancer (LPPC-NRN), 4200-172 Porto, Portugal.
Publikováno v:
Biology [Biology (Basel)] 2022 Jul 20; Vol. 11 (7). Date of Electronic Publication: 2022 Jul 20.